Healthcare Infection Control Practices Advisory Committee (HICPAC), 57294 [05-19559]
Download as PDF
<![CDATA[
57294
Federal Register / Vol. 70, No. 189 / Friday, September 30, 2005 / Notices
Routine Administrative Matters.
PERSON TO CONTACT FOR INFORMATION:
Mr. Robert Biersack, Press Officer,
Telephone: (202) 694–1220.
Mary W. Dove,
Secretary of the Commission.
[FR Doc. 05–19763 Filed 9–28–05; 3:08 am]
BILLING CODE 6715–01–M
Centers for Disease Control and
Prevention
National Institute for Occupational
Safety and Health Advisory Board on
Radiation and Worker Health
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
Name: Healthcare Infection Control
Practices Advisory Committee.
Times and Dates: 8:30 a.m.–5 p.m.,
October 24, 2005; 8:30 a.m.–4 p.m., October
25, 2005.
Place: Sheraton Colony Square, 188 14th
Street, NE., Atlanta, Georgia 30361.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
providing advice and guidance to the
Secretary; the Assistant Secretary for Health;
the Director, CDC; and the Director, National
Center for Infectious Diseases (NCID),
regarding (1) the practice of hospital
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters to be Discussed: Agenda items will
include finalizing recommendations for
isolation precautions to prevent transmission
of infectious agents in healthcare settings,
update on public reporting, and updates on
CDC activities of interest to the committee.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Harriette Lynch, Committee Management
Specialist, HICPAC, Division of Healthcare
Quality Promotion, NCID, CDC, l600 Clifton
Road, NE, M/S A–07, Atlanta, Georgia 30333,
telephone 404/498–1182.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
16:14 Sep 29, 2005
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Aug<31>2005
Dated: September 26, 2005.
Diane Allen,
Acting Director, Management Analysis and
Services Office Centers for Disease Control
and Prevention.
[FR Doc. 05–19559 Filed 9–29–05; 8:45 am]
Jkt 205001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting:
Name: Advisory Board on Radiation and
Worker Health (ABRWH), National Institute
for Occupational Safety and Health (NIOSH)
and Subcommittee for Dose Reconstruction
and Site Profile Reviews.
Subcommittee Meeting Time and Date: 10
a.m.–3:30 p.m., October 17, 2005.
Committee Meeting Times and Dates: 8:30
a.m.–5 p.m., October 18, 2005. 8:30 a.m.–4:30
p.m., October 19, 2005.
Place: Knoxville Marriott Hotel, 500 Hill
Avenue, SE., Knoxville, Tennessee, 37915.
Telephone: (865) 637–1234.
Status: Open to the public, limited only by
the space available. The meeting space
accommodates approximately 75 people.
Background: The ABRWH was established
under the Energy Employees Occupational
Illness Compensation Program Act
(EEOICPA) of 2000 to advise the President,
delegated to the Secretary of Health and
Human Services (HHS), on a variety of policy
and technical functions required to
implement and effectively manage the new
compensation program. Key functions of the
Board include providing advice on the
development of probability of causation
guidelines which have been promulgated by
HHS as a final rule, advice on methods of
dose reconstruction which have also been
promulgated by HHS as a final rule, advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000 the President delegated
responsibility for funding, staffing, and
operating the Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, and renewed on July 27, 2005.
Purpose: This board is charged with (a)
providing advice to the Secretary, HHS, on
the development of guidelines under
Executive Order 13179; (b) providing advice
to the Secretary, HHS, on the scientific
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
validity and quality of dose reconstruction
efforts performed for this Program; and (c)
upon request by the Secretary, HHS, advise
the Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such radiation
doses may have endangered the health of
members of this class.
Matters to be Discussed: The agenda for the
Subcommittee Meeting includes Individual
Dose Reconstruction Reviews; Site Profile
Reviews, particularly Bethlehem Steel, Y–12,
Savannah River Site and Rocky Flats; and a
Review of Task 3 of the S. Cohen &
Associates Contract (SC&A). The Board
meeting’s agenda includes Subcommittee
Reports on the agenda items listed; SC&A
Task 4; Site Profile Reviews; SEC Activities,
specifically National Bureau of Standards
Petition Evaluation and § 83.14 Petition
Evaluation(s); Science Issues; Program
Updates; and Conflict of Interest Discussions.
The evening public comment periods are
scheduled for October 17, 2005 from 4 p.m.–
5 p.m. and October 18, 2005 from 7 p.m.–8
p.m.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Contact Person for More Information: Dr.
Lewis V. Wade, Executive Secretary, NIOSH,
CDC, 4676 Columbia Parkway, Cincinnati,
Ohio 45226, telephone 513–533–6825, fax
513–533–6826.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: September 26, 2005.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 05–19563 Filed 9–29–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10148]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
AGENCY:
E:\FR\FM\30SEN1.SGM
30SEN1
]]>Agencies
[Federal Register Volume 70, Number 189 (Friday, September 30, 2005)]
[Notices]
[Page 57294]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-19559]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
Name: Healthcare Infection Control Practices Advisory Committee.
Times and Dates: 8:30 a.m.-5 p.m., October 24, 2005; 8:30 a.m.-4
p.m., October 25, 2005.
Place: Sheraton Colony Square, 188 14th Street, NE., Atlanta,
Georgia 30361.
Status: Open to the public, limited only by the space available.
Purpose: The committee is charged with providing advice and
guidance to the Secretary; the Assistant Secretary for Health; the
Director, CDC; and the Director, National Center for Infectious
Diseases (NCID), regarding (1) the practice of hospital infection
control; (2) strategies for surveillance, prevention, and control of
infections (e.g., nosocomial infections), antimicrobial resistance,
and related events in settings where healthcare is provided; and (3)
periodic updating of guidelines and other policy statements
regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters to be Discussed: Agenda items will include finalizing
recommendations for isolation precautions to prevent transmission of
infectious agents in healthcare settings, update on public
reporting, and updates on CDC activities of interest to the
committee.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Harriette Lynch, Committee
Management Specialist, HICPAC, Division of Healthcare Quality
Promotion, NCID, CDC, l600 Clifton Road, NE, M/S A-07, Atlanta,
Georgia 30333, telephone 404/498-1182.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: September 26, 2005.
Diane Allen,
Acting Director, Management Analysis and Services Office Centers for
Disease Control and Prevention.
[FR Doc. 05-19559 Filed 9-29-05; 8:45 am]
BILLING CODE 4163-18-P
